Diabetic versus non-diabetic rhino-orbito-cerebral mucormycosis.

Parya AbdolalizadehMohsen Bahmani KashkouliBehzad KhademiNasser KarimiParisa HamamiAcieh Es'haghi

Published in: Mycoses (2020)

Patients', globe and vision survivals were not different between diabetic and non-diabetic patients with ROCM. They were 51%, 40% and 20% in diabetic and 70%, 50% and 37% in non-diabetic ROCM.

Keyphrases

type diabetes
wound healing
end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
blood brain barrier